EarningsQ2 2026 Earnings Report

Biodexa Pharmaceuticals (5MP2) Q2 2026 Earnings Report

0 Followers

DE:5MP2 Q2 2026 EPS Results

Actual EPS€0.00

Consensus EPS€0.00

Beat/MissMet expectations

One Year Ago EPS>-€0.01

Actual Revenue€0.00

Expected Revenue€0.00

Beat/MissMet expectations

YoY Revenue Growth―

QuarterQ2 2026

Date09/11/2026

TimeAfter Close

Conference CallFriday, September 11, 2026

DE:5MP2 Upcoming Earnings

Biodexa Pharmaceuticals's next earnings date is estimated for April 23, 2027, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Apr 23, 2027	2026 (Q4)	- / -	>-0.001	―
Sep 11, 2026	2026 (Q2)	0.00 / 0.00	>-0.001	―
Mar 27, 2026	2025 (Q4)	- / >-0.01	-0.029	96.97% (+0.03)
Sep 12, 2025	2025 (Q2)	-0.02 / >-0.01	-1.491	99.94% (+1.49)
Apr 11, 2025	2024 (Q4)	-0.03 / -0.03	-15.78	99.81% (+15.75)
Sep 26, 2024	2024 (Q2)	-1.00 / -1.49	―	―
Apr 19, 2024	2023 (Q4)	-15.77 / -15.78	-485050.269	100.00% (+485034.49)
Sep 29, 2023	2023 (Q2)	- / -	-71740.324	―
Apr 28, 2023	2022 (Q4)	- / -485050.27	-284140.777	-70.71% (-200909.49)
Sep 14, 2022	2022 (Q2)	- / -358701.62	-616141.52	41.78% (+257439.90)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed